About this trial
The purpose of this study is to evaluate the safety and effectiveness of the MedCline Sleep System in reducing symptoms related to mild OSA.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis with mild obstructive sleep apnea (AHI 5-14.9)
PSG or HST performed within last 24 months
Individuals aged 18 or older
Must routinely sleep on a standard mattress and must be able to accommodate the width of the MedCline Sleep System (30")
Disqualifiers
Diagnosis of moderate to severe OSA (AHI >15) or central sleep apnea
Has undergone surgical procedures for sleep apnea within the last six months
Clinically significant cardiac or respiratory conditions that may interfere with the study intervention or outcomes.
Chronic pain or musculoskeletal disorders, e.g., spinal deformities, scoliosis, kyphosis, back injuries, spinal compressions, or injuries that may affect their ability to sleep comfortably in a lateral position
Trial design
Single group
Treatments tested in this trial
MedCline Sleep System
DeviceThe MedCline Sleep System is an at-home positional therapy device to be placed on a bed surface.
Treatment groups
Trial outcomes
Primary outcomes
Reduction of AHI on Apnea-Hypopnea Index scale
Change in apneas per hour as measured by PSG (in-lab)
Reduction of ODI on Oxygen Desaturation Index Scale
Change in oxygen desaturation per hour via PSG (in-lab)
Secondary outcomes
Reduction in Snoring
Change in snoring during night
Sponsors and contacts
Click on the lead sponsor to view all of their trials.